Comparison of the immunoreactivity of Rituximab antibody labeled with either I-125 or Re-188 for Radioimmunotherapy

  • Darwati, Siti (Radiopharmaceuticals, National Nuclear Energy Agency) ;
  • Choi, Tae-Hyun (Lab. of Cyclotron Application, Korea Institute of Radiological and Medical Sciences (KIRAMS)) ;
  • Chung, Hye-Kyung (Lab. of Cyclotron Application, Korea Institute of Radiological and Medical Sciences (KIRAMS)) ;
  • Lee, Tae-Sup (Lab. of Cyclotron Application, Korea Institute of Radiological and Medical Sciences (KIRAMS)) ;
  • Chung, Wee-Sup (Lab. of Cyclotron Application, Korea Institute of Radiological and Medical Sciences (KIRAMS)) ;
  • Woo, Kwang-Sun (Lab. of Cyclotron Application, Korea Institute of Radiological and Medical Sciences (KIRAMS)) ;
  • Lee, Myung-Jin (Lab. of Cyclotron Application, Korea Institute of Radiological and Medical Sciences (KIRAMS)) ;
  • Kim, So-Yeon (Lab. of Cyclotron Application, Korea Institute of Radiological and Medical Sciences (KIRAMS)) ;
  • Chung, Jae-Ho (Lab. of Cyclotron Application, Korea Institute of Radiological and Medical Sciences (KIRAMS)) ;
  • Choi, Chang-Woon (Lab. of Cyclotron Application, Korea Institute of Radiological and Medical Sciences (KIRAMS)) ;
  • Lim, Sang-Moo (Lab. of Cyclotron Application, Korea Institute of Radiological and Medical Sciences (KIRAMS))
  • Published : 2004.10.28